• Media Centre
  • Investor relations
  • Client area
  • Client area
  • Stewardship policy
  • Annual reports service

Form of Proxy

BIONTECH SE

Notes

No. Proposition For Against Abstain
1

Resolution on the appropriation of the balance sheet profit for the 2025 financial year

2

Resolution on the approval of the actions of the Management Board

3

Resolution on the approval of the actions of the Supervisory Board

4

Resolution on the appointment of the auditor and the Group auditor for the 2026 financial year and the auditor for any audit or review of interim reports

5

Resolution on the approval of the Compensation Report

6

Resolution on the amendment of Section 9 para. 1 of the Articles of Association to increase the size of the Supervisory Board

7

Elections to the Supervisory Board: Mr. Helmut Jeggle

8

Elections to the Supervisory Board: Prof. Dr. Anja Morawietz

9

Elections to the Supervisory Board: Prof. Dr. Rudolf Staudigl

10

Elections to the Supervisory Board: Dr. Susanne Schaffert

11

Elections to the Supervisory Board: Prof. Dr. Iris Loew-Friedrich

12

Resolution on the amendment of Section 16 para. 5 of the Articles of Association to reauthorize the Management Board to provide for the holding of a virtual Annual General Meeting

13

Resolution on the cancellation of the existing Authorized Capital 2025 and the creation of new Authorized Capital 2026 with the possibility of excluding subscription rights and corresponding amendment to the Articles of Association

14

Resolution on the approval of the conclusion of a domination and profit and loss transfer agreement between BioNTech SE and BioNTech Discovery GmbH